Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DCTPP1 | Q9H773 | 7/20 | 0.34 |
| ▸ | MAPT | P10636 | 4/20 | 0.33 |
| ▸ | UCHL1 | P09936 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | F2RL3 | Q96RI0 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PIK3C2B | O00750 | 3/20 | 0.31 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6495592 | 0.86 | TSHR (0.38) | DCTPP1CYP3A4CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL6491248 | 0.81 | DCTPP1 (0.38) | DCTPP1MAPTTP53F2RL3KMT2A | |
| SCHEMBL6489201 | 0.79 | DCTPP1 (0.40) | DCTPP1MAPTF2RL3 | |
| SCHEMBL6488896 | 0.77 | DCTPP1 (0.40) | DCTPP1MAPTTP53CYP3A4CYP2D6 | |
| SCHEMBL6501386 | 0.74 | MCL1 (0.48) | DCTPP1 | |
| SCHEMBL6488456 | 0.74 | DCTPP1 (0.44) | DCTPP1 | |
| SCHEMBL6489130 | 0.73 | MAPT (0.40) | DCTPP1MAPTTP53 | |
| SCHEMBL6488241 | 0.73 | MCL1 (0.43) | DCTPP1MAPTKMT2A | |
| SCHEMBL6497299 | 0.73 | PDE3B (0.40) | DCTPP1MAPTKMT2A | |
| SCHEMBL6488966 | 0.72 | RXRA (0.41) | DCTPP1TP53PIK3C2BALOX5AP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050014812-A1 | Benzimidazole compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014812-A1 | Benzimidazole compounds | SLC5A1, SLC5A2, G6PD | DCTPP1 1534/4885MAPT 3168/4885UCHL1 2423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.